The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated ...

Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® ...

Summary • Omeros Corporation’s stock jumped 72.1% to $15.06 following FDA approval of Yartemlea, its therapy for TA-TMA.• ...

Omeros Corporation OMER recently announced that the FDA approved its YARTEMLEA (narsoplimab-wuug) to treat hematopoietic stem ...

Trapped in a hell he helped make, a lone hacker aboard a space station far from home sneaks and fights his way through horrible mutants and killer robots in order to take down the monstrous artificial ...

Generative AI is infiltrating everything you do online, including how you find information. If you're bored with traditional search, check out the top AI search engines we've tried.

Scientists have identified a gut microbe molecule, trimethylamine (TMA), that shows promise in controlling blood sugar and combating insulin resistance. This discovery offers a new direction for ...

The new grading structure under the Competency-Based Education (CBE) system is going to reshape how learners transitioning to Senior School will be assessed and placed. The system, built on cumulative ...

本研究针对热带地区肉牛母体营养不均衡影响后代肉品质的产业难题，通过多组学整合分析揭示了不同孕期营养策略（全期补充PP、后期补充FP、仅矿物质NP）对后代背最长肌和皮下脂肪组织的长效编程效应。研究发现NP组显著激活PPAR信号通路和鞘脂代谢，而补充 ...